Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Fluticasone propionate/azelastine hydrochloride (Nasal)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dymista 137micrograms/dose / 50micrograms/dose nasal spray
1202010Y0BBAAAA
|
Dymista | Fluticasone propionate/azelastine hydrochloride (Nasal) | Ear, Nose and Oropharynx | 125,495 |
|
Fluticasone propionate 50microg/Azelastine 137microg/dose
1202010Y0AAAAAA
|
Fluticasone propionate/azelastine hydrochloride | Fluticasone propionate/azelastine hydrochloride (Nasal) | Ear, Nose and Oropharynx | 72,958 |
|
Flomister 137micrograms/dose / 50micrograms/dose nasal spray
1202010Y0BCAAAA
|
Flomister | Fluticasone propionate/azelastine hydrochloride (Nasal) | Ear, Nose and Oropharynx | 203 |
|
Dymista Control 137microg/dose / 50microg/dose nsl spy
1202010Y0BBABAA
|
Dymista | Fluticasone propionate/azelastine hydrochloride (Nasal) | Ear, Nose and Oropharynx | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.